-
-
-
-
-
-
-
Skye Bioscience (SKYE) PT Lowered to $6 at Piper Sandler
-
-
-
-
-
-
-
Moderna (MRNA) PT Raised to $69 at Piper Sandler
-
-
-
-
-
-
-
Piper Sandler Highlights Karyopharm Therapeutics (KPTI) As a 2026 Top Pick
-
-
-
-
-
-
-
Arrowhead Pharma (ARWR) PT Raised at Piper Sandler Following FDA Approval
-
-
-
-
-
-
-
CAMP4 Therapeutics Corp (CAMP) PT Lowered to $12 at Piper Sandler
-
-
-
-
-
-
-
Piper Sandler Assumes Acrivon Therapeutics Inc (ACRV) at Overweight
-
-
-
-
-
-
-
Piper Sandler Reiterates Overweight Rating on Legend Biotech Corp. (LEGN)
-
385 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

